Antidepressants surveillance in wastewater: Overview extraction and detection
Author(s) -
Elda M. Melchor-Martínez,
Mildred G. Jiménez-Rodríguez,
Manuel Martínez-Ruiz,
Samantha Ayde Peña-Benavides,
Hafiz M.N. Iqbal,
Roberto ParraSaldívar,
Juan Eduardo SosaHernández
Publication year - 2020
Publication title -
case studies in chemical and environmental engineering
Language(s) - English
Resource type - Journals
ISSN - 2666-0164
DOI - 10.1016/j.cscee.2020.100074
Subject(s) - anxiety , pandemic , sewage , antidepressant , psychiatry , covid-19 , medicine , environmental science , environmental engineering , infectious disease (medical specialty) , disease
The COVID-19 pandemic has been one of the biggest challenges worldwide. The psychological disorders associated with the pandemic causing depression, insomnia, post-traumatic stress disorder (PTSD) and anxiety reduce emotional stability. Different antidepressant drugs with several mechanisms of action are used with a prescription. The excretion of the compounds and their metabolites reach municipal wastewaters and enter sewage treatment plants with a low rate of remotion of pharmaceutical compounds and the releasing on the environment. Several effects on aquatic species exposed to antidepressants have been reported as the impact in gene transcription, reproduction cycles, predator defense, and motility. The aim of this work is to resume the common antidepressants detected in wastewater around the world and show the increment of its use during SARS-CoV-2 crisis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom